- Home
- CARV vs TRAW Comparison
CARV vs TRAW Comparison
Compare CARV & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- TRAW
- Stock Information
- Founded
- CARV 1948
- TRAW 1998
- Country
- CARV United States
- TRAW United States
- Employees
- CARV N/A
- TRAW N/A
- Industry
- CARV Savings Institutions
- TRAW
- Sector
- CARV Finance
- TRAW
- Exchange
- CARV Nasdaq
- TRAW NYSE
- Market Cap
- CARV 7.3M
- TRAW 7.8M
- IPO Year
- CARV 1994
- TRAW 2013
- Fundamental
- Price
- CARV $1.41
- TRAW $1.65
- Analyst Decision
- CARV
- TRAW
- Analyst Count
- CARV 0
- TRAW 0
- Target Price
- CARV N/A
- TRAW N/A
- AVG Volume (30 Days)
- CARV 20.0K
- TRAW 3.5M
- Earning Date
- CARV 07-15-2025
- TRAW 05-15-2025
- Dividend Yield
- CARV N/A
- TRAW N/A
- EPS Growth
- CARV N/A
- TRAW N/A
- EPS
- CARV N/A
- TRAW N/A
- Revenue
- CARV $24,056,000.00
- TRAW $227,000.00
- Revenue This Year
- CARV N/A
- TRAW $3.81
- Revenue Next Year
- CARV N/A
- TRAW $30.43
- P/E Ratio
- CARV N/A
- TRAW N/A
- Revenue Growth
- CARV N/A
- TRAW 0.44
- 52 Week Low
- CARV $1.30
- TRAW $0.97
- 52 Week High
- CARV $2.39
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- CARV 50.30
- TRAW 54.15
- Support Level
- CARV $1.35
- TRAW $1.30
- Resistance Level
- CARV $1.50
- TRAW $2.58
- Average True Range (ATR)
- CARV 0.09
- TRAW 0.23
- MACD
- CARV -0.01
- TRAW 0.07
- Stochastic Oscillator
- CARV 30.00
- TRAW 34.04
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.